ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1599

NF-Kb Inducing Kinase (NIK) Is a Key Regulator of Inflammation-Induced Angiogenesis

A.R. Noort1, K.P.M. van Zoest1, P. Koolwijk2, D.V. Novack3, M.J. Siemerink4, P. P. Tak5 and S.W. Tas6, 1Division of Clinical Immunology & Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 2Physiology, Institute for Cardiovascular Research (ICaR-VU) / VU University Medical Center, Amsterdam, Netherlands, 3Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, 4Department of Ophthalmology and Department of Cell Biology and Histology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 5Division of Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam and GlaxoSmithKline, Amsterdam, Netherlands, 6Division of Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Angiogenesis, endothelial cells, inflammation and signal transduction

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cell-cell Adhesion, Cell Trafficking and Angiogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: In rheumatoid arthritis (RA) synovial tissue (ST) angiogenesis can be observed already in the earliest phase of disease, which may be critical in the switch from acute to chronic inflammation. The chemokine CXCL12, which is induced via the non-canonical nuclear factor-kB (NF-kB) pathway, plays an important role in angiogenesis, lymphocyte transendothelial migration, and the homing of endothelial progenitor cells. Therefore, the non-canonical pathway, with its key mediator NF-kB inducing kinase (NIK), may play an important role in pathological angiogenesis and the perpetuation of synovial inflammation in RA.

Objectives: To study the role of non-canonical NF-kB signaling in pathological angiogenesis in RA.

Methods: Expression of NIK and CXCL12 in RA ST was evaluated using immunofluorescence microscopy (IF). The angiogenic potential of endothelial cells (EC) was studied in vitro using the tube formation assay and siRNA-mediated gene silencing. Microvessel outgrowth was studied ex vivo by comparing WT and NIK-/-mice in the aortic ring assay. Physiological (developmental) angiogenesis was evaluated in these mice by isolectin B4 staining of the retina followed by confocal microscopy. Finally, the contribution of NIK to synovial angiogenesis was studied in vivo in antigen-induced arthritis (AIA).

Results: NIK was highly expressed in EC in RA ST and co-localized with the EC marker vWF in small (newly formed) blood vessels. NIK, p52 and CXCL12 were expressed both in EC in small blood vessels and in PNAd+ high endothelial venules. In vitro, EC treated with stimuli that induce non-canonical NF-kB signaling (i.e. lymphotoxin, LIGHT, CD40L) significantly enhanced tube formation 2,5-fold (p<0.05), which could be completely blocked by siRNA targeting NIK or IKKα, but not completely by IKKβ (canonical NF-kB pathway). Aortic rings from WT and NIK-/- mice showed normal TNF- and VEGF-induced microvessel outgrowth. In contrast, whereas non-canonical NF-kB stimuli induced microvessel outgrowth in WT mice (unstim 29.94 ± 6.08 vs. LT 159.1 ± 50.24 vs. LIGHT 110.3 ± 17.68 (mm^2) p<0.05), no microvessel outgrowth was observed in aortic rings from NIK-/- mice (unstim 28.74 ± 15.89 vs. LT 45.9 ± 16.71 vs. LIGHT 43.41 ± 15.73 (mm^2)). In line with this, NIK-/- mice exhibited normal developmental angiogenesis in the retina, but a 50% reduction in pathological angiogenesis in synovial inflammation (blood vessels in synovial tissue WT 20 ± 5.07 vs. NIK-/-10.2 ± 3.02).

Conclusion: NIK is preferentially expressed in EC in RA ST. Induction of non-canonical NF-kB signaling in EC resulted in enhanced angiogenesis in vitro, and siRNA-mediated selective blockade of this pathway abrogated these effects. Moreover, NIK-/-mice exhibited normal developmental and VEGF-induced angiogenesis, but reduced pathological angiogenesis in AIA. These findings point towards an important role of the non-canonical NF-kB pathway in pathological angiogenesis associated with chronic (synovial) inflammation. This could be exploited for the development of future new therapies for RA.

Acknowledgement: SWT was supported by a VENI grant and a Clinical Fellowship from the Netherlands Organisation for Scientific Research (ZON-MW).


Disclosure:

A. R. Noort,
None;

K. P. M. van Zoest,
None;

P. Koolwijk,
None;

D. V. Novack,
None;

M. J. Siemerink,
None;

P. P. Tak,
None;

S. W. Tas,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nf-kb-inducing-kinase-nik-is-a-key-regulator-of-inflammation-induced-angiogenesis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology